BVF as of March 31, 2018
Portfolio Holdings for BVF
BVF holds 43 positions in its portfolio as reported in the March 2018 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Chemocentryx | 9.9 | $98M | 7.2M | 13.60 | |
Ironwood Pharmaceuticals (IRWD) | 8.7 | $86M | 5.5M | 15.43 | |
Array BioPharma | 8.4 | $83M | 5.1M | 16.32 | |
Blueprint Medicines (BPMC) | 6.1 | $60M | 656k | 91.70 | |
ArQule | 4.8 | $47M | 16M | 2.88 | |
Syndax Pharmaceuticals (SNDX) | 4.7 | $46M | 3.2M | 14.23 | |
Merus N V (MRUS) | 4.5 | $45M | 2.4M | 18.53 | |
Concert Pharmaceuticals I equity | 4.5 | $44M | 1.9M | 22.90 | |
Cytokinetics (CYTK) | 4.2 | $41M | 5.7M | 7.20 | |
Anaptysbio Inc Common (ANAB) | 4.1 | $40M | 386k | 104.08 | |
Xoma Corp Del (XOMA) | 3.1 | $30M | 1.5M | 20.23 | |
Xencor (XNCR) | 2.7 | $27M | 902k | 29.98 | |
Cti Biopharma | 2.7 | $27M | 6.9M | 3.90 | |
Kura Oncology (KURA) | 2.6 | $25M | 1.4M | 18.75 | |
Pieris Pharmaceuticals (PIRS) | 2.5 | $25M | 3.6M | 6.82 | |
Biolinerx Ltd-spons | 2.3 | $23M | 26M | 0.87 | |
Corvus Pharmaceuticals (CRVS) | 2.3 | $23M | 2.0M | 11.53 | |
Infinity Pharmaceuticals (INFIQ) | 2.1 | $21M | 9.8M | 2.10 | |
Arcus Biosciences Incorporated (RCUS) | 2.0 | $20M | 1.3M | 15.44 | |
Spero Therapeutics (SPRO) | 1.5 | $15M | 1.0M | 14.25 | |
Oncomed Pharmaceuticals | 1.4 | $14M | 4.3M | 3.18 | |
Immune Design | 1.4 | $14M | 4.1M | 3.30 | |
Erytech Pharma Sa | 1.3 | $13M | 625k | 21.00 | |
Spring Bk Pharmaceuticals In | 1.3 | $13M | 832k | 15.38 | |
Vbi Vaccines | 1.1 | $11M | 3.1M | 3.50 | |
Gtx Inc Del | 1.1 | $11M | 610k | 17.75 | |
Forward Pharma A/s | 1.1 | $10M | 4.8M | 2.17 | |
Regulus Therapeutics | 1.0 | $10M | 14M | 0.72 | |
Verastem | 0.8 | $8.2M | 2.7M | 2.98 | |
Aduro Biotech | 0.8 | $7.5M | 807k | 9.30 | |
Albireo Pharma | 0.7 | $7.3M | 225k | 32.57 | |
Tocagen | 0.6 | $6.0M | 505k | 11.85 | |
Contrafect | 0.6 | $5.6M | 3.5M | 1.59 | |
Molecular Templates | 0.6 | $5.5M | 689k | 8.00 | |
Alpine Immune Sciences (ALPN) | 0.6 | $5.4M | 676k | 8.00 | |
Genocea Biosciences | 0.5 | $5.3M | 5.0M | 1.05 | |
Sunesis Pharmaceuticals Inc Ne | 0.5 | $4.6M | 1.7M | 2.72 | |
Xenon Pharmaceuticals (XENE) | 0.4 | $3.5M | 721k | 4.90 | |
Protagonist Therapeutics (PTGX) | 0.3 | $3.5M | 406k | 8.59 | |
Vical | 0.2 | $2.0M | 1.4M | 1.45 | |
Essa Pharma | 0.2 | $1.9M | 10M | 0.19 | |
Loxo Oncology | 0.1 | $506k | 4.4k | 115.37 | |
Orexigen Therapeutics | 0.0 | $107k | 535k | 0.20 |